603108 Stock Overview
Shanghai Runda Medical Technology Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Shanghai Runda Medical Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.49 |
| 52 Week High | CN¥25.39 |
| 52 Week Low | CN¥11.77 |
| Beta | 0.39 |
| 1 Month Change | -6.99% |
| 3 Month Change | 32.26% |
| 1 Year Change | -9.76% |
| 3 Year Change | 55.51% |
| 5 Year Change | 88.10% |
| Change since IPO | 307.87% |
Recent News & Updates
Earnings Tell The Story For Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) As Its Stock Soars 39%
Oct 22
These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Oct 18Recent updates
Earnings Tell The Story For Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) As Its Stock Soars 39%
Oct 22These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Oct 18Shanghai Runda Medical Technology (SHSE:603108) Has A Somewhat Strained Balance Sheet
Jun 26Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) Earnings Haven't Escaped The Attention Of Investors
Jun 04Does Shanghai Runda Medical Technology (SHSE:603108) Deserve A Spot On Your Watchlist?
Mar 21Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Stock Rockets 31% But Many Are Still Ignoring The Company
Mar 04These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Feb 27Shareholder Returns
| 603108 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -2.1% | -1.5% | -1.2% |
| 1Y | -9.8% | -18.1% | 11.8% |
Return vs Industry: 603108 exceeded the CN Life Sciences industry which returned -18.1% over the past year.
Return vs Market: 603108 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 603108 volatility | |
|---|---|
| 603108 Average Weekly Movement | 10.0% |
| Life Sciences Industry Average Movement | 10.1% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603108 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603108's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,300 | Hui Liu | www.rundamedical.com |
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technical services; and logistic services.
Shanghai Runda Medical Technology Co., Ltd. Fundamentals Summary
| 603108 fundamental statistics | |
|---|---|
| Market cap | CN¥11.07b |
| Earnings (TTM) | CN¥40.27m |
| Revenue (TTM) | CN¥8.43b |
275.0x
P/E Ratio1.3x
P/S RatioIs 603108 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603108 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.43b |
| Cost of Revenue | CN¥6.21b |
| Gross Profit | CN¥2.22b |
| Other Expenses | CN¥2.18b |
| Earnings | CN¥40.27m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.067 |
| Gross Margin | 26.34% |
| Net Profit Margin | 0.48% |
| Debt/Equity Ratio | 126.3% |
How did 603108 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield154%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Runda Medical Technology Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Lin Yang | Haitong International Research Limited |